Your browser doesn't support javascript.
loading
Erlotinib for coexisting typical bronchial carcinoid and advanced lung adenocarcinoma: does the epidermal growth factor receptor mutation status matter?
Drpa, Gordana; Sreter, Katherina B; Manojlovic, Spomenka; Kukulj, Suzana.
Afiliação
  • Drpa G; Thoracic Oncology Unit, Department of Respiratory Diseases 'Jordanovac', University Hospital Centre Zagreb.
  • Sreter KB; Department of Clinical Immunology, Pulmonology and Rheumatology, University Hospital Centre 'Sestre Milosrdnice'.
  • Manojlovic S; Department of Pathology, Clinical Hospital Dubrava.
  • Kukulj S; Institute of Pathology, School of Medicine, University of Zagreb.
Anticancer Drugs ; 29(3): 281-285, 2018 03.
Article em En | MEDLINE | ID: mdl-29280916

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Brônquicas / Tumor Carcinoide / Adenocarcinoma / Receptores ErbB / Cloridrato de Erlotinib / Neoplasias Pulmonares / Mutação / Neoplasias Primárias Múltiplas Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Brônquicas / Tumor Carcinoide / Adenocarcinoma / Receptores ErbB / Cloridrato de Erlotinib / Neoplasias Pulmonares / Mutação / Neoplasias Primárias Múltiplas Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article